|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | |
| C07K 14/605 |
| (11) | Number of the document | 2934566 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13810957.4 |
| Date of filing the European patent application | 2013-12-19 | |
| (97) | Date of publication of the European application | 2015-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/077307 |
| Date | 2013-12-19 |
| (87) | Number | WO 2014/096145 |
| Date | 2014-06-26 |
| (30) | Number | Date | Country code |
| 12306647 | 2012-12-21 | EP |
| (72) |
HAACK, Torsten, DE
WAGNER, Michael, DE
HENKEL, Bernd, DE
STENGELIN, Siegfried, DE
EVERS, Andreas, DE
LORENZ, Martin, DE
LORENZ, Katrin, DE
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | EXENDIN-4 DERIVATIVES AS DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS |
| EXENDIN-4 DERIVATIVES AS DUAL GLP1/GIP OR TRIGONAL GLP1/GIP/GLUCAGON AGONISTS |